Works matching IS 21623619 AND DT 2025 AND VI 14 AND IP 1

Results: 17

The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00601-2
By:
- Caratelli, Sara;
- De Paolis, Francesca;
- Silvestris, Domenico Alessandro;
- Baldari, Silvia;
- Salvatori, Illari;
- Tullo, Apollonia;
- Lanzilli, Giulia;
- Gurtner, Aymone;
- Ferri, Alberto;
- Valle, Cristiana;
- Padovani, Simona;
- Cesarini, Valeriana;
- Sconocchia, Tommaso;
- Cifaldi, Loredana;
- Arriga, Roberto;
- Spagnoli, Giulio Cesare;
- Ferrone, Soldano;
- Venditti, Adriano;
- Rossi, Piero;
- Pesole, Graziano
Publication type:
Article
Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00611-0
By:
- Zhu, Yufu;
- Zhang, Xuefeng;
- Jin, Jiaqi;
- Wang, Xiaoqian;
- Liu, Yang;
- Gao, Jian;
- Hang, Diancheng;
- Fang, Lin;
- Zhang, Hengzhu;
- Liu, Hongmei
Publication type:
Article
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00605-y
By:
- Yao, Mingyue;
- Yan, Wenzhong;
- Wang, Yafang;
- Zhao, Yu;
- Xu, Xiaowei;
- Chen, Yujun;
- Yu, Chengcheng;
- Li, Yingnian;
- Jiang, Hualiang;
- Shen, Jie;
- Cheng, Jianjun;
- Xie, Chengying
Publication type:
Article
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00608-9
By:
- Guoyun, Jiang;
- Yuefeng, Qin;
- Zhenglan, Huang;
- Zuowei, Yuan;
- Hongyan, Zhou;
- Ying, Yuan;
- Wenli, Feng
Publication type:
Article
Distinct response to IL-1β blockade in liver- and lung-specific metastasis mouse models of pancreatic cancer with heterogeneous tumor microenvironments.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00607-w
By:
- Chen, Sophia Y.;
- Kung, Heng-Chung;
- Espinoza, Birginia;
- Washington, India;
- Chen, Kai;
- Mu, Kaiyi;
- Zlomke, Haley;
- Loycano, Michael;
- Wang, Rulin;
- Burns, William R.;
- Fu, Juan;
- Zheng, Lei
Publication type:
Article
Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00603-0
By:
- Li, Xinyu;
- Zhao, Haiying
Publication type:
Article
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00602-1
By:
- Cheng, Zhe;
- Huang, Huichao;
- Yin, Meilong;
- Liu, Huaizheng
Publication type:
Article
A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies.
Published in:
2025
By:
- Bentivegna, Sofia;
- Almosailleakh, Marwa;
- Zhao, Lin-Pierre;
- Schuster, Mikkel Bruhn;
- Benquet, Sébastien;
- Balhuizen, Alexander;
- Munch-Petersen, Helga Fibiger;
- Sjö, Lene Dissing;
- Andersen, Mads Hald;
- Dulphy, Nicolas;
- Porse, Bo;
- Grønbæk, Kirsten
Publication type:
Letter
EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes.
Published in:
2025
By:
- Zhang, Qi;
- Luo, Yingwan;
- Ye, Li;
- Wang, Yuxia;
- Wang, Lu;
- Yang, Wenli;
- Lang, Wei;
- Zhu, Shuanghong;
- Jiang, Lingxu;
- Jin, Weimei;
- Mei, Chen;
- Zhou, Xinping;
- Ren, Yanling;
- Ma, Liya;
- Xu, Gaixiang;
- Bowattage, Bowatte Gedara Lakmal Vimukthi Bandara;
- Tong, Hongyan;
- Sun, Jie
Publication type:
Letter
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00597-9
By:
- Shou, Songting;
- Maolan, Ayidana;
- Zhang, Di;
- Jiang, Xiaochen;
- Liu, Fudong;
- Li, Yi;
- Zhang, Xiyuan;
- Geer, En;
- Pu, Zhenqing;
- Hua, Baojin;
- Guo, Qiujun;
- Zhang, Xing;
- Pang, Bo
Publication type:
Article
Structural basis of FpGalNase and its combination with FpGalNAcDeAc for efficient A-to-O blood group conversion.
Published in:
2025
By:
- Zhou, Meiling;
- Luo, Kaishan;
- Su, Chao;
- Sun, Yan;
- Huang, Zuyan;
- Ma, Shuo;
- Gao, Xun;
- Wang, Jiwei;
- Zhang, Chen;
- Han, Pengcheng;
- Wu, Guoqiu
Publication type:
Letter
Construction and characterization of chimeric FcγR T cells for universal T cell therapy.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00595-x
By:
- Zhao, Juanjuan;
- Chen, Manling;
- Li, Xudong;
- Chen, Zhaoqi;
- Li, Wei;
- Guo, Rongqun;
- Wang, Min;
- Jiang, Zhongxing;
- Song, Yongping;
- Wang, Jianxiang;
- Liu, Delong
Publication type:
Article
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-024-00590-8
By:
- Chan, Sharon Pei Yi;
- Yeo, Celestia Pei Xuan;
- Hong, Boon Hao;
- Tan, Evelyn Mui Cheng;
- Beh, Chaw Yee;
- Yeo, Eugenia Li Ling;
- Poon, Dennis Jun Jie;
- Chu, Pek Lim;
- Soo, Khee Chee;
- Chua, Melvin Lee Kiang;
- Chow, Edward Kai-Hua
Publication type:
Article
A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-024-00594-4
By:
- Sun, Dantong;
- Hou, Helei;
- Feng, Feiyue;
- Wu, Weizheng;
- Tan, Jingyu;
- Xie, Tongji;
- Liu, Jiayu;
- Wang, Jinsong;
- Qian, Haili;
- Li, Junling;
- Xing, Puyuan
Publication type:
Article
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-024-00593-5
By:
- Yang, Tingting;
- Dong, Yetian;
- Zhang, Mingming;
- Feng, Jingjing;
- Fu, Shan;
- Xiao, Pingnan;
- Hong, Ruimin;
- Xu, Huijun;
- Cui, Jiazhen;
- Huang, Simao;
- Wei, Guoqing;
- Kong, Delin;
- Geng, Jia;
- Chang, Alex H.;
- Huang, He;
- Hu, Yongxian
Publication type:
Article
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-024-00592-6
By:
- Huang, Ruihao;
- Wang, Xiaoqi;
- Yan, Hongju;
- Tan, Xu;
- Ma, Yingying;
- Wang, Maihong;
- Han, Xiao;
- Liu, Jia;
- Gao, Li;
- Gao, Lei;
- Jing, Guangjun;
- Zhang, Cheng;
- Wen, Qin;
- Zhang, Xi
Publication type:
Article
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.
Published in:
Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-024-00591-7
By:
- Peng, Hao;
- Chao, Zheng;
- Wang, Zefeng;
- Hao, Xiaodong;
- Xi, Zirui;
- Ma, Sheng;
- Guo, Xiangdong;
- Zhang, Junbiao;
- Zhou, Qiang;
- Qu, Guanyu;
- Gao, Yuan;
- Luo, Jing;
- Wang, Zhihua;
- Wang, Jing;
- Li, Le
Publication type:
Article